0 Commentaires
0 Parts
507 Vue
0 Aperçu
Rechercher
Découvrez de nouvelles personnes, créer de nouvelles connexions et faire de nouveaux amis
-
Fil d’actualités
- EXPLORER
-
Pages
-
Groupes
-
Evènements
-
Blogs
-
Offres
-
Emplois
-
Courses
-
Connectez-vous pour aimer, partager et commenter!
-
Blood Cancer Drugs Market Industry Analysis and Opportunity AssessmentThe blood cancer drugs market continues to evolve rapidly as advancements in oncology research, targeted therapies, and immunotherapy reshape treatment approaches worldwide. Blood cancers—including leukemia, lymphoma, and myeloma—remain among the most diagnosed and complex cancer types, requiring continuous innovation in drug development. Pharmaceutical companies are increasingly...0 Commentaires 0 Parts 210 Vue 0 Aperçu
-
Blood Cancer Drugs Market Regional Landscape: Key Opportunities, Challenges, and Future TrendsPolaris Market Research has published a new report titled Blood Cancer Drugs Market Share, Size, Trends, Industry Analysis Report, By Blood Cancer Type (Lymphoma, Leukemia, Myeloma); By Drugs, By Treatment Type; By Region; Segment Forecast, 2026-2034 that delivers up-to-date analysis with analyses of the current and future effects of the continuously changing industry landscape....0 Commentaires 0 Parts 760 Vue 0 Aperçu
-
Cancer Drugs Market Forecast 2031: Investment Surge and R&D Innovations Driving ExpansionCancer treatment has evolved significantly with the emergence of innovative therapeutic approaches and cutting-edge technologies. The shift from conventional chemotherapy to targeted therapies, immunotherapy, and precision medicine has transformed how cancer is managed globally. Cancer Drugs Market OverviewThe cancer drugs market size is projected to reach US$ 516.15 billion by 2031 from...0 Commentaires 0 Parts 265 Vue 0 Aperçu
-
Cancer Drugs Market: Key Trends, Regional Insights, and Strategic Growth Opportunities by 2031Cancer drugs also referred to as oncology or anticancer drugs are pharmaceutical products developed to treat cancer by eliminating cancer cells, inhibiting tumor growth, or activating the body’s immune system to combat malignant cells. These therapies include a broad spectrum of treatment options such as conventional chemotherapy, targeted therapy, immunotherapy, and hormone therapy....0 Commentaires 0 Parts 747 Vue 0 Aperçu
-
Cancer Therapeutics and Supportive Care Drugs Market Opportunity AssessmentThe Cancer Therapeutics and Supportive Care Drugs Market is witnessing strong expansion driven by rising cancer prevalence, ongoing innovation in oncology therapeutics, and increasing emphasis on patient quality of life. According to market estimates, the Cancer Therapeutics and Supportive Care Drugs Market is projected to grow from US$ 16.14 billion in 2025 to US$ 33.74 billion by 2034,...0 Commentaires 0 Parts 286 Vue 0 Aperçu
-
Colombia Gastric Cancer Drugs Market expected to reach USD 47.73 million by 2029"Executive Summary Colombia Gastric Cancer Drugs Market : CAGR Value Data Bridge Market Research analyzes that the market is growing with a CAGR of 8.5% in the forecast period of 2022 to 2029 and is expected to reach USD 47.73 million by 2029. This global Colombia Gastric Cancer Drugs Market research report is organized by collecting market research data from different corners of...0 Commentaires 0 Parts 1KB Vue 0 Aperçu
-
GCC Oncology/Cancer Drugs Market Trends, Insights & Forecast Data 2028The GCC Oncology/Cancer Drugs Market reports delivers an in-depth assessment of market size, share, and emerging trends, offering valuable insights into growth opportunities. It examines market segmentation and definitions, highlighting core components and key drivers of expansion. By applying SWOT and PESTEL analyses, the study evaluates the sector’s strengths, weaknesses,...0 Commentaires 0 Parts 1KB Vue 0 Aperçu
-
Generic Oncology Drugs Market Drivers: Rising Cancer Prevalence and Cost-Effective Treatment DemandThe global generic oncology drugs market is expanding significantly as healthcare systems seek cost-effective solutions to manage the growing burden of cancer. Rising treatment costs and increasing demand for accessible therapies are encouraging the adoption of generic alternatives across the globe. Generic Oncology Drugs Market Drivers indicate that a combination of economic,...0 Commentaires 0 Parts 421 Vue 0 Aperçu
-
Global Cancer Drugs Market Set for Exponential Growth, Targeting USD 1.81 Billion by 2032 as Immunotherapies Reshape Oncology LandscapeMarket Projected to Accelerate at 4.71% CAGR Driven by Precision Medicine Adoption and the Rise of Novel Cell and Gene Therapies The global Cancer Drugs Market, highlighting a profound shift toward curative and highly targeted therapeutic modalities. The market, valued at a substantial USD 1.19 Billion in 2023, is projected to reach USD 1.81 Billion by 2032, recording a robust Compound Annual...0 Commentaires 0 Parts 1KB Vue 0 Aperçu
-
Kidney Cancer Drugs Market Size Projected to Reach USD 10.3 Billion by 2032“According to a new report published by Introspective Market Research, Kidney Cancer Drugs Market by Drug Type, Therapy Type, and Distribution Channel, The Global Kidney Cancer Drugs Market Size Was Valued at USD 6.4 Billion in 2023 and is Projected to Reach USD 10.3 Billion by 2032, Growing at a CAGR of 5.4% from 2024–2032.” The Kidney Cancer Drugs Market comprises...0 Commentaires 0 Parts 975 Vue 0 Aperçu
-
North America Anemia Drugs Market Set to Reach USD 5.9 Billion by 2032 Amid Rising CKD and Cancer CasesAccording to a new report from Intel Market Research, the North America Anemia Drugs Market was valued at USD 4,200 million in 2024 and is projected to grow from USD 4,410 million in 2025 to reach USD 5,900 million by 2032, growing at a CAGR of approximately 4.3% during the forecast period (2025–2032). This steady expansion is driven by the high and growing prevalence of chronic kidney...0 Commentaires 0 Parts 297 Vue 0 Aperçu
-
Anti-Emetic Drugs Market Size, Share and Trends Forecast to 2030According to the latest report published by Data Bridge Market Research, the Anti-Emetic Drugs Market Data Bridge Market Research analyses that the global anti-emetic drugs market which was USD 7,543.13 million in 2022, is expected to reach USD 12,840.23 million by 2030, and is expected to undergo a CAGR of 6.06% during the forecast period of 2023 to 2030 Global market research...0 Commentaires 0 Parts 335 Vue 0 Aperçu
-
Brigatinib API Market Growing at 8.1% CAGR Through 2034 GloballyAccording to a new report from Intel Market Research, the global Brigatinib API market was valued at USD 42.5 million in 2025 and is projected to reach USD 89.7 million by 2034, growing at a robust CAGR of 8.1% during the forecast period (2026–2034). This growth is propelled by the increasing global incidence of non-small cell lung cancer, particularly ALK-positive cases among...0 Commentaires 0 Parts 624 Vue 0 Aperçu
-
Cell Cycle Inhibitors Market Advancing Targeted Cancer TreatmentsIn-Depth Study on Executive Summary Cell Cycle Inhibitors Market Size and Share CAGR Value Global cell cycle inhibitors market size was valued at USD 9.84 billion in 2024 and is projected to reach USD 21.71 billion by 2032, with a CAGR of 10.40% during the forecast period of 2025 to 2032. This Cell Cycle Inhibitors Market report is structured with the thorough market analysis carried...0 Commentaires 0 Parts 1KB Vue 0 Aperçu
-
Crizotinib Drugs Market Growing at 6.7% CAGR Through 2034According to a new report from Intel Market Research, the global Crizotinib Drugs market was valued at USD 582.4 million in 2025 and is projected to reach USD 1,043.7 million by 2034, growing at a CAGR of 6.7% during the forecast period (2026–2034). This growth is propelled by the rising global incidence of lung cancer, increasing adoption of molecular diagnostic testing for genetic...0 Commentaires 0 Parts 563 Vue 0 Aperçu
-
Cyproterone Acetate Market Analysis and Growth Drivers Accelerating Global Expansion Through 2034The global Cyproterone Acetate Market is set for significant growth through 2034, fueled by increasing demand for hormonal therapies and rising awareness of endocrine disorders. According to The Insight Partners, the Cyproterone Acetate Market size is projected to expand from US$ 331.14 million in 2025 to US$ 531.88 million by 2034, registering a compound annual growth rate (CAGR) of 5.2%...0 Commentaires 0 Parts 654 Vue 0 Aperçu
-
Gastroesophageal Junction Adenocarcinoma Therapeutics Market Overview, Growth Analysis, Trends and Forecast By 2032"Executive Summary Gastroesophageal Junction Adenocarcinoma Therapeutics Market : During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of 17.56%, primarily driven by the rising prevalence and treatments advancements Gastroesophageal Junction Adenocarcinoma Therapeutics Market report provides the market potential for each geographical region...0 Commentaires 0 Parts 2KB Vue 0 Aperçu
Plus de résultats
English
Arabic
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek